MedTrace Logo

Thiol/Disulphide Homeostasis and Albumin in Vertigo

NCT04070664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2019-08-28

No results posted yet for this study

Summary

Vertigo is a common complaint in the Emergency Department (ED). The differential diagnosis of central and peripheral vertigo is a difficult issue that directly affects mortality. Magnetic resonance imaging (MRI) is the preferred diagnostic tool, but may not be suitable in all patients due to logistic and economic conditions. In this study, the investigators evaluated the role of thiol/disulfide homeostasis (TDH) parameters and ischemia modified albumin (IMA) levels to assist in the value of being used instead of MRI.

Conditions

  • Vertigo, Peripheral
  • Vertigo, Central Origin
  • Oxidative Stress
  • Diagnosis

Sponsors & Collaborators

  • Ankara Training and Research Hospital

    collaborator OTHER

  • Ankara City Hospital Bilkent

    lead OTHER

Eligibility

Min Age
51 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04070664 on ClinicalTrials.gov